correspond
susann
pfefferl
spfefferl
uked
citat
style
articl
pfefferl
susann
reucher
svenja
domin
marc
evalu
quantit
rtpcr
assay
detect
emerg
coronaviru
use
high
throughput
system
euro
surveil
http
doi
face
emerg
sever
acut
respiratori
syndrom
coronaviru
highvolum
respiratori
test
demand
laboratori
worldwid
evalu
perform
molecular
assay
detect
highthroughput
platform
coba
use
open
channel
integr
laboratorydevelop
assay
observ
good
analyt
perform
clinic
specimen
fulli
autom
workflow
enabl
highthroughput
test
minim
handson
time
offer
fast
reliabl
result
januari
previous
unknown
coronavirusnow
name
sever
acut
respiratori
syndrom
coronaviru
identifi
caus
agent
cluster
suspici
pneumonia
case
wuhan
china
world
health
organ
declar
public
health
emerg
intern
concern
end
januari
march
confirm
case
fatal
countri
attribut
viru
abil
quickli
confirm
clear
suspect
case
crucial
global
outbreak
scenario
especi
clinic
manifest
difficult
distinguish
respiratori
infect
influenza
molecular
diagnost
key
detect
emerg
viru
varieti
suitabl
assay
made
avail
earli
cours
outbreak
notabl
corman
et
al
other
howev
implement
diagnost
laboratori
usual
reli
manual
pcr
setup
requir
high
degre
human
interact
execut
interpret
thu
limit
capac
scale
handl
larg
number
sampl
studi
report
analyt
evalu
laboratorydevelop
test
detect
use
open
channel
util
channel
coba
system
custommad
primerprob
set
base
previous
publish
assay
target
e
gene
optimis
use
autom
system
primer
probe
order
idt
dna
technolog
coralvil
unit
state
us
primer
modifi
base
penultim
base
prevent
format
primer
dimer
zen
doublequench
probe
idt
use
order
lower
background
fluoresc
master
mix
mmx
cassett
test
prepar
combin
forward
primer
nm
revers
primer
nm
probe
nm
atccttactgcgcttcgiowa
black
togeth
water
mixtur
mix
ml
transfer
reagent
cassett
mmx
cassett
deliv
fullprocess
control
preload
intern
control
ic
rna
togeth
primer
probe
ic
detect
assay
default
instrument
set
coba
mni
util
channel
softwar
roch
lo
gato
us
temperatur
profil
use
rtpcr
reaction
summaris
tabl
assay
perform
evalu
swab
sampl
clinic
specimen
use
collect
univers
medic
center
hamburgeppendorf
ukehh
sampl
mix
roch
coba
pcr
media
guanidin
hydrochlorid
trishcl
buffer
incub
min
load
onto
coba
system
apart
sampl
prepar
step
manual
step
requir
entir
workflow
novel
assay
limit
detect
lod
interrun
variabl
crossreact
respiratori
pathogen
determin
invitro
transcrib
rna
ivt
rna
e
gene
purifi
rna
sarscov
strain
use
posit
control
obtain
via
european
viru
archiv
global
evag
http
wwweuropeanvirusarchivecom
limit
detect
uct
determin
analys
eight
replic
dilut
seri
contain
ivt
rna
dilut
eswab
medium
copan
brescia
itali
modifi
liquid
ami
medium
roch
coba
pcr
medium
copiesml
eight
neg
sampl
lod
copiesml
copi
per
reaction
detect
probabl
figur
figur
estim
interintrarun
variabl
analys
two
concentr
ca
lod
spike
ivt
rna
five
replic
neg
sampl
five
replic
two
run
minim
deviat
observ
cycl
threshold
ct
lod
ct
lod
fals
posit
result
occur
potenti
interfer
uct
respiratori
pathogen
includ
human
cov
strain
evalu
analys
previous
determin
clinic
sampl
extern
qualiti
control
assess
panel
instand
germani
contain
lysat
infect
cell
none
organ
detect
uct
assay
tabl
confirm
high
specif
assay
virus
within
betacoronaviru
subgenu
sarb
coviru
outbreak
novel
pathogen
ongo
situat
repres
challeng
molecular
diagnost
howev
identif
agent
sequenc
public
specif
pcr
assay
gener
use
process
took
sever
week
year
ago
accomplish
day
rapid
pace
identif
share
inform
come
respons
local
laboratori
abl
implement
avail
assay
provid
test
outbreak
strain
equal
short
timefram
furthermor
demand
unpredict
may
suddenli
spike
even
outsid
primari
endem
area
put
test
capac
strain
potenti
caus
delay
exampl
februari
entir
cruis
ship
carri
almost
passeng
crew
quarantin
port
yokohama
japan
hundr
peopl
test
viru
short
period
time
autom
solut
molecular
diagnost
help
handl
larg
number
sampl
scale
keep
pace
fluctuat
demand
system
use
studi
fulli
autom
nucleic
acid
extract
purif
amplif
detect
among
other
previous
demonstr
laboratorydevelop
test
adapt
fulli
autom
pcr
platform
coba
system
brief
prepar
clinic
sampl
load
directli
devic
requir
handson
time
manual
step
reduc
manual
step
reduc
handson
time
reduc
min
min
compar
dark
blue
curv
specif
signal
ivtrna
copiesml
copiesml
copiesml
copiesml
light
blue
curv
signal
intern
control
convent
workflow
usual
involv
autom
extract
pcr
perform
separ
procedur
inclus
fullprocess
control
reaction
facilit
handl
result
allow
interpret
personnel
familiar
rtpcr
diagnost
system
pass
clinic
evalu
varieti
viral
bacteri
target
also
use
blood
safeti
test
anoth
diagnost
field
larg
number
sampl
clear
pcrbase
screen
test
studi
demonstr
good
analyt
perform
adapt
assay
swab
sampl
lod
copiesml
eg
copiesprocess
detect
probabl
roughli
line
result
publish
corman
et
al
report
lod
rna
copi
per
reaction
detect
probabl
correspond
copiesml
base
reaction
volum
note
manual
determin
lod
usual
involv
ad
purifi
target
rna
directli
reagent
mix
amplif
wherea
studi
control
materi
purifi
rna
spike
sampl
underw
full
workflow
coba
devic
includ
extract
purif
therefor
differ
nomin
analyt
perform
expect
one
import
limit
studi
reli
spikedin
materi
could
valid
perform
assay
use
clinic
sampl
howev
believ
assay
design
highthroughput
molecular
test
could
use
ongo
outbreak
situat
demonstr
commerci
pcr
platform
enhanc
outbreak
readi
emerg
pathogen
allow
larg
number
patient
screen
reason
timefram
necessari
note
natur
screen
test
target
singl
viral
gene
posit
result
alway
confirm
independ
pcr
recommend
final
want
stress
import
close
coordin
local
refer
centr
public
health
author
determin
clinic
indic
test
well
handl
confirm
case
contact
precaut
origin
version
articl
publish
march
wrong
sequenc
present
probe
quencher
request
author
correct
read
black
chang
made
march
